Robert V. LaPenta Jr., Director at TherapeuticsMD, Inc. (TXMD), bought 5,000 shares at $3.58 ($18K) on 2014-05-09, disclosed to the SEC on 2014-05-13.
Open-market purchase of $18k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.58 | 2,000 | $7K | 39.1% |
| 2 | $3.72 | 3,000 | $11K | 60.9% |
| Total | $3.66 avg | 5,000 | $18K | 100% |